Observation on the Effect of Triamcinolone Local Injection in Urethral Syndrome.
- Author:
Soo Young AHN
1
Author Information
1. Department of Urology, Seoul Adventist Hospital Seoul, Korea.
- Publication Type:Original Article
- Keywords:
triamcinolone;
urethral syndrome
- MeSH:
Cicatrix;
Dysuria;
Female;
Humans;
Inflammation;
Triamcinolone Acetonide;
Triamcinolone*
- From:Korean Journal of Urology
1979;20(1):81-87
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The term "urethral syndrome" is used to describe, in the female, a syndrome of recurrent episodes of frequency of voiding and dysuria, without evidence of infection in the urine. The treatment for this syndrome is usually not easy in office practice. The submucosal injection of triamcinolone acetonide around Skene's gland to decrease inflammation and scarring was done for 20 patients with urethral syndrome and the following results were observed. 1) Of a total of 20 cases, 7 cases had excellent effect( 35%), 8 cases were improved (40%) , and other 5 cases got no effect ( 25%). So overall effect rate was 75%. 2) No side effect was noted in all patients. 3) Triamcinolone periurethral injection is a simple, effective office procedure for urethral syndrome, but it is desirable to have further evaluation for more patients and longer period.
